SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-20-000445
Filing Date
2020-03-31
Accepted
2020-03-30 17:43:15
Documents
2
Period of Report
2020-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AGEX THERAPEUTICS, INC. 8-K a52196301.htm 8-K 16844
2 EXHIBIT 99.1 a52196301ex99_1.htm EX-99.1 311194
  Complete submission text file 0001157523-20-000445.txt   329170
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 20758695
SIC: 2834 Pharmaceutical Preparations